|
Harold H. Rumph has been President and Director of the Company since March of 2003 and bring with him a career devoted to technical sales and marketing. From 1988 to 2003 he was founder and owner of a high tech business providing computerized scheduling services to the construction industry. From 1986 to 1988, Mr. Rumph was Director of Sales and Marketing for JE Research, Inc. From 1980 to 1986 he was a founder, President, and Director of Biogenix, Inc. This company was involved in the development, manufacturing, and marketing of in-hospital bedside and ambulatory Patient Monitoring Systems. Biogenix was also involved with research and development of antiviral peptides from cobra venoms, including clinical trials under FDA-issued Investigational New Drug applications. Prior to the above Mr. Rumph led sales teams and was responsible for marketing at Harris Communications, Harris Computers, Memorex Corporation, Xerox Corporation, Cincinnati Milacron, Amdahl Corporation, RCA Computers, and IBM. Mr. Rumph received his BS degree from the United States Naval Academy.
Harold H. Rumph has been a Director of ReceptoPharm, Inc. (ReceptoPharm) since March 2003. Prior to his election to the board, Mr. Rumph had served as a consultant to ReceptoPharm since August 2002. At that time he was operating a high tech business providing computerized scheduling services to the construction industry. Prior to this, Mr. Rumph was a founder, President, and Director of Biogenix, Inc. Biogenix was involved in the development, manufacturing, and marketing of Patient Monitoring Systems. These products were both in-hospital bedside systems and ambulatory systems. Biogenix was also involved in the research and development of anti viral peptides including clinical trials under FDA-issued IND's. Mr. Rumph received his BS degree from the USNA. | 